CERo Therapeutics Holdings, Inc. , an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.
Cero Therapeutics Holdings stock last closed at $0.64, up 3.4% from the previous day, and has decreased 99.55% in one year. It has underperformed other stocks in the Biotechnology industry by 0.22 percentage points. Cero Therapeutics Holdings stock is currently +19.48% from its 52-week low of $0.53, and -99.63% from its 52-week high of $171.00.
As of Apr 21, 2025, there are 5.38M shares of CERO outstanding. The market cap of CERO is $3.43M. In the past 24 hours, 187,881 CERO shares were traded.
You need an online brokerage account to access the NASDAQ market and buy CERO stock.
Based on our research, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the best brokerage, the next step is to fill out some personal details so you are able to invest in CERO stock today.
Now that you have opened your account on our top ranked stock trading app, your next step is to transfer the money for your investment:
Check out the video below for more details depositing money into your new brokerage account.
Once you have identified the best place to buy Cero Therapeutics Holdings stock, it's crucial to research their stock before you invest, so you can comprehend the risk and upside.
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on CERO's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge CERO's fair value.
You can access more valuation research on CERO's stock here.
Over the last 12 months, insiders at CERO have sold more shares than they have bought.
Yk Bioventures Opportunities GP I LLC, 10% Owner of CERO, was the latest CERO insider to sell. They sold $179,934.48 worth of CERO shares on Dec 13, 2024.
Learn more about who owns CERO stock here.
No, Cero Therapeutics Holdings doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
There are two primary options:
Press the Open Trade button and your broker will execute your order.
If you need additional help with buying stocks on eToro, click the how to video below:
Now that you own some CERO shares, you'll want to keep up with your investment.
Start a watchlist to get the latest updates about your CERO stock.
To reiterate, here are the 6 steps to buy stock in Cero Therapeutics Holdings:
If you need a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Cero Therapeutics Holdings, click below.